Health
EBMT trial shows improvements in treatment of Severe Aplastic Anaemia – Science Codex
The European Society for Blood and Marrow Transplantation (EBMT), Europe’s collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of the phase III RACE trial during EBMTs virtual 46th Annual Meeting. Preliminary data show that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in patients with Severe Aplastic Anaemia (SAA).
SAA is a condition in which the bone m…
-
Noosa News21 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News19 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News19 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News20 hours agoGood character references restricted in rape cases in Queensland